Repligen Corp [RGEN] stock is trading at $126.55, up 1.73%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RGEN shares have gain 4.43% over the last week, with a monthly amount drifted -10.20%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repligen Corp [NASDAQ: RGEN] stock has seen the most recent analyst activity on April 29, 2025, when Wolfe Research upgraded its rating to a Outperform but kept the price target unchanged to $160 for it. Previously, Evercore ISI started tracking the stock with In-line rating on March 18, 2025, and set its price target to $155. On February 10, 2025, TD Cowen initiated with a Buy rating and assigned a price target of $200 on the stock. Canaccord Genuity started tracking the stock assigning a Hold rating and suggested a price target of $165 on December 17, 2024. Wolfe Research initiated its recommendation with a Peer Perform. Wells Fargo started tracking with a Overweight rating for this stock on August 28, 2024, and assigned it a price target of $180. In a note dated June 26, 2024, Deutsche Bank upgraded an Buy rating on this stock and revised its target price from $180 to $155.
Repligen Corp [RGEN] stock has fluctuated between $102.96 and $182.52 over the past year. Currently, Wall Street analysts expect the stock to reach $193.86 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $126.55 at the most recent close of the market. An investor can expect a potential return of 53.19% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
Repligen Corp [NASDAQ:RGEN] reported sales of 650.43M for the trailing twelve months, which represents a growth of 10.44%. Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.04%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.34.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Repligen Corp’s Current Ratio is 6.79. In addition, the Quick Ratio stands at 5.79 and the Cash Ratio stands at 4.59. Considering the valuation of this stock, the price to sales ratio is 10.93, the price to book ratio is 3.58.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Director, that happened on May 15 ’25 when 26447.0 shares were sold. Director, Hunt Anthony completed a deal on May 15 ’25 to buy 26447.0 shares. Meanwhile, Director Hunt Anthony sold 26756.0 shares on Mar 17 ’25.
